In silico prediction of ROCK II inhibitors by different classification approaches
- PMID: 28770474
- DOI: 10.1007/s11030-017-9772-5
In silico prediction of ROCK II inhibitors by different classification approaches
Abstract
ROCK II is an important pharmacological target linked to central nervous system disorders such as Alzheimer's disease. The purpose of this research is to generate ROCK II inhibitor prediction models by machine learning approaches. Firstly, four sets of descriptors were calculated with MOE 2010 and PaDEL-Descriptor, and optimized by F-score and linear forward selection methods. In addition, four classification algorithms were used to initially build 16 classifiers with k-nearest neighbors [Formula: see text], naïve Bayes, Random forest, and support vector machine. Furthermore, three sets of structural fingerprint descriptors were introduced to enhance the predictive capacity of classifiers, which were assessed with fivefold cross-validation, test set validation and external test set validation. The best two models, MFK + MACCS and MLR + SubFP, have both MCC values of 0.925 for external test set. After that, a privileged substructure analysis was performed to reveal common chemical features of ROCK II inhibitors. Finally, binding modes were analyzed to identify relationships between molecular descriptors and activity, while main interactions were revealed by comparing the docking interaction of the most potent and the weakest ROCK II inhibitors. To the best of our knowledge, this is the first report on ROCK II inhibitors utilizing machine learning approaches that provides a new method for discovering novel ROCK II inhibitors.
Keywords: Classification model; Docking; Kinase; Machine learning; Privileged substructures; ROCK II inhibitors.
Similar articles
-
A review on ROCK-II inhibitors: From molecular modelling to synthesis.Bioorg Med Chem Lett. 2016 May 15;26(10):2383-2391. doi: 10.1016/j.bmcl.2016.03.113. Epub 2016 Apr 1. Bioorg Med Chem Lett. 2016. PMID: 27080184 Review.
-
Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery.J Chem Inf Model. 2013 Nov 25;53(11):3009-20. doi: 10.1021/ci400331p. Epub 2013 Nov 6. J Chem Inf Model. 2013. PMID: 24144102
-
Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.Mol Divers. 2017 Aug;21(3):661-675. doi: 10.1007/s11030-017-9743-x. Epub 2017 May 8. Mol Divers. 2017. PMID: 28484935
-
Determination of potential selective inhibitors for ROCKI and ROCKII isoforms with molecular modeling techniques: structure based docking, ADMET and molecular dynamics simulation.J Biomol Struct Dyn. 2019 Jun;37(9):2457-2463. doi: 10.1080/07391102.2018.1491420. Epub 2018 Oct 26. J Biomol Struct Dyn. 2019. PMID: 30047850
-
Rho kinase inhibitors: a patent review (2012 - 2013).Expert Opin Ther Pat. 2014 Mar;24(3):295-307. doi: 10.1517/13543776.2014.863279. Epub 2013 Nov 27. Expert Opin Ther Pat. 2014. PMID: 24283930 Review.
Cited by
-
Identification of Drug Targets and Their Inhibitors in Yersinia pestis Strain 91001 through Subtractive Genomics, Machine Learning, and MD Simulation Approaches.Pharmaceuticals (Basel). 2023 Aug 9;16(8):1124. doi: 10.3390/ph16081124. Pharmaceuticals (Basel). 2023. PMID: 37631039 Free PMC article.
-
Activity Models of Key GPCR Families in the Central Nervous System: A Tool for Many Purposes.J Chem Inf Model. 2023 Jun 12;63(11):3248-3262. doi: 10.1021/acs.jcim.2c01531. Epub 2023 May 31. J Chem Inf Model. 2023. PMID: 37257045 Free PMC article.
-
Chemical Distance Measurement and System Pharmacology Approach Uncover the Novel Protective Effects of Biotransformed Ginsenoside C-Mc against UVB-Irradiated Photoaging.Oxid Med Cell Longev. 2022 Feb 9;2022:4691576. doi: 10.1155/2022/4691576. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35186187 Free PMC article.
-
In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L.Front Pharmacol. 2021 Dec 7;12:755396. doi: 10.3389/fphar.2021.755396. eCollection 2021. Front Pharmacol. 2021. PMID: 34950027 Free PMC article.
-
A review on machine learning approaches and trends in drug discovery.Comput Struct Biotechnol J. 2021 Aug 12;19:4538-4558. doi: 10.1016/j.csbj.2021.08.011. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34471498 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
- No.81273817/National Natural Science Foundation of China
- No.81473740/National Natural Science Foundation of China
- No.81673627/National Natural Science Foundation of China
- No.20134425110003/Doctoral Fund of Education Ministry of China
- No.2012A080202017/Guangdong Provincial Major Science and Technology for Special Program of China
LinkOut - more resources
Full Text Sources
Other Literature Sources
